Literature DB >> 9222

The effect of pH on folic acid absorption in man.

J F MacKenzie, R I Russell.   

Abstract

1. Pteroylmonoglutamic acid (PteGlu) absorption has been measured by using the technique of small-intestinal perfusion with tritiated PteGlu in normal subjects and in patients with coeliac disease. 2. At similar intrajejunal pH, patients with untreated coeliac disease have significantly less PTEGlu than normal subjects and patients with treated coeliac disease. 3. The "resting" pH in the jejunum did not differ markedly between normal subjects and patients with coeliac disease. 4. Increasing pH decreased PteGlu absorption in patients with coeliac disease and in normal subjects. 5. These findings suggest that PteGlu malabsorption in coeliac disease is not due to abnormally high pH in the jejunum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9222     DOI: 10.1042/cs0510363

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  5 in total

1.  Acid microclimate in coeliac and Crohn's disease: a model for folate malabsorption.

Authors:  M L Lucas; B T Cooper; F H Lei; I T Johnson; G K Holmes; J A Blair; W T Cooke
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

2.  Plasma propranolol levels in Crohn's disease and coeliac disease.

Authors: 
Journal:  Br Med J       Date:  1977-02-12

3.  The influence of buffer pH, glucose and sodium ion concentration on the acid microclimate in rat proximal jejunum in vitro.

Authors:  M L Lucas; F H Lei; J A Blair
Journal:  Pflugers Arch       Date:  1980-05       Impact factor: 3.657

4.  Impairment of folic acid absorption by oral pancreatic extracts.

Authors:  R M Russell; S K Dutta; E V Oaks; I H Rosenberg; A C Giovetti
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

5.  Intestinal folic acid absorption and the acid microclimate. The effects of compounds relevant to folate malabsorption.

Authors:  J A Blair; M L Lucas; S K Swanston-Flatt
Journal:  Pflugers Arch       Date:  1981-11       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.